FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2024. Recent …
DELRAY BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2024. Quarterly Highlights for Q1, Fiscal 2025 …
SEATTLE, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Xylitol, also known as birch sugar, wood sugar, or birch bark extract, is a sugar substitute product commonly found in foods labeled “sugar free”, “no sugar added”, “reduced sugar”, “diabetic friendly” and other …
EAGLE, Idaho, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the second quarter of …
Q2 Revenue Grew 6% Year-Over-Year to $43.5 Million, Including 90.5% Recurring Revenue GAAP Gross Margin Expands to 67.5%; Adjusted Gross Margin Rises to 77.5% Year-Over-Year, Net Income Increased by $11.1 Million, EPS Improved to $0.01 from $(1.13) and …
Highlights Second quarter revenue grew 15% year-over-year to $212 million, driven by Prenatal (25%), Pharmacogenomics (22%), and Hereditary Cancer (19%). Second quarter GAAP earnings per share improved to $(0.41) from $(1.42) in the second quarter of 2023; …
RICHMOND, Va., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced financial results for the second quarter …
INGLEWOOD, CA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cognos Therapeutics (“Cognos” and “the Company”), a leading innovator in medical technology, today proudly announced the formation of its Industry Advisory Board (IAB) and the appointment of Mark Webster as …
Singota Solutions has expanded its European footprint with a new state-of-the-art -40°C and -20°C pallet storage facility near Milan, Italy. BLOOMINGTON, IN, UNITED STATES, August 6, 2024 /EINPresswire.com/ -- Singota Solutions Announces -40 °C Pallet …
DES MOINES—Iowa Attorney General Brenna Bird today joined a 21-state brief, urging a federal court to uphold Congress’s law that protects American privacy rights by requiring TikTok to cut ties with the Chinese Communist Party or face a national ban. …
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Keith Cummings, M.D., Chief Financial Officer, and Éric Lefebvre, M.D., Chief Medical Officer, will participate in a fireside chat …
Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion Rate Board Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative …
MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with …
– Q2 2024 revenue of $22.5 million excluding discontinued operations and NY increased 42.5% year-over-year – – Operating income of $5.8 million driven by consistent execution in core markets – – Recently extended credit facility supports the continued …
Presented promising interim clinical results from the ongoing study of palazestrant in combination with ribociclib at the 2024 ESMO Breast Cancer Congress. Updated results expected to be presented at a future medical meeting Successfully completed …
MINNEAPOLIS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with …
Upcoming poster presentation of protocol-defined TAMARACK Phase 2 mCRPC study data at ESMO in September Received $100.0 million in milestones related to Incyte’s advancement of ZYNYZ® (retifanlimab-dlwr) subsequent to quarter-end Confirming cash runway …
SCOTTSDALE, Ariz., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing FDA-approved prescription …
Boise, Idaho – State employees who become foster parents will now enjoy a new benefit – eight weeks of paid parental leave after welcoming a foster child in their home. “Right now, we have more children in need of a foster family than we have families to …
Cash Generation of $217 million in Q2, including working capital recovery Introducing Cash Generation guidance of $350 million to $600 million in 2025; reiterating Cash Generation guidance of $50 million to $125 million in Q4 ($200 million to $500 million …
05 days 07:35:33
